Serologicals

Serologicals is a leading worldwide provider of specialty human antibodies and other blood-related products and services to major healthcare companies. The Company's services, including donor recruitment, donor management and clinical testing services, enable the Company to provide value-added specialty antibodies that are used as the active ingredients in therapeutic products for the treatment and management of such medical indications as Rh incompatibility in newborns, rabies and hepatitis and in diagnostic products such as blood typing reagents and diagnostic test kits. In addition, the Company collects source plasma containing non-specialty antibodies from which a number of products, primarily intravenous immune globulin (IVIG), a product containing a broad spectrum of antibodies used in the treatment of a wide variety of medical indications, are derived. As of March 15, 1999, the Company conducted its operations through a national network of 64 donor centers and through laboratories located in the United States and the United Kingdom. The Companyalso operates two monoclonal antibody manufacturing facilities in Scotland. Furthermore, the Company operates a clinical trial site dedicated to the management and performance of clinical trials for the pharmaceutical and biotechnology industries. On December 29, 1998, subsequent to year end, the Company purchased substantially all of the domestic assets of Pentex Blood Proteins ("Pentex"), a unit of Bayer Corporation. Located in Kankakee, Illinois, Pentex supplies a broad line of purified animal and human blood proteins to the diagnostic and biopharmaceutical industries.

Contact Details: 780 Park North Blvd. Atlanta GA 30021 United States of America Tel: 404 296 5595 Fax: 770 465 2144 Email: WWW: www.serologicals.com

Loading...

Recent Publications by Serologicals:
The use of siRNA to validate immunofluorescence studies. Cellular immunofluorescence studies can be validated by using either...	9th December, 2006	Serologicals Corporation, Charlottesville, VA, USA.	Methods Mol Biol. 2007;356:245-51.

BioNews Results for Serologicals:
Executive Profile: Martin Madaus: 'Whole new world': Millipore chief marks tenure with acquisitions, growth	Biz Journals:  Sep 22 2008 12:41PM Matching: serologicals
Executive Profile: Martin Madaus: 'Whole new world': Millipore chief marks tenure with acquisitions, growth	East Bay Business Journal:  Sep 22 2008 5:42AM Matching: serologicals
ArunA Biomedical Names Harold Ingalls to its Board of Directors	KSLA:  Sep 10 2008 10:50AM Matching: serologicals
ArunA Biomedical Names Harold Ingalls to its Board of Directors	KLFY:  Sep 10 2008 6:29AM Matching: serologicals
ArunA Biomedical Names Harold Ingalls to its Board of Directors	TickerTech.com:  Sep 9 2008 10:25PM Matching: serologicals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Serologicals news.

Serologicals Patents:
US Patent No.	Title
6743899	Process for inactivating prions in lipoproteins
6531581	Purines and pyrimidines linked to a quencher

Serologicals (SERO) Financial information Links from Barchart
SERO Quote from from Barchart.com
SERO Chart from from Barchart.com
SERO Profile from from Barchart.com
SERO Opinion from from Barchart.com
→View more Serologicals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 358 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: Serologicals 2008 | t | t | t | t | www.serologicals.com | Serologicals Corporation uk tel | Serologicals | t | serologicals | .

Search for more companies in Atlanta

Search for more companies in GA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Serologicals